Kolkata: A surge in pneumonia and COPD patients has left several private hospitals close to full occupancy, leading to a ...

Mepolizumab reduced COPD exacerbations in patients with eosinophilic inflammation, highlighting the potential of ...

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...

Century Health, a pioneer in applying AI to real-world clinical data to accelerate research, and Tessel Biosciences, a biotechnology company that combines human organoids and machine learning to model ...

Sanofi gains EMA Orphan Drug status for efdoralprin alfa, a phase II biologic for AATD-related emphysema with promising dosing data.

A greater proportion of women vs. men with COPD or bronchiectasis had their first health care visit within 6 months of ...

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

A study of nearly 900 adults indicates that although smoking is still the main risk factor for lung function loss, systemic inflammation and obesity also increase the risk of developing chronic ...

EMA grants orphan designation to Sanofi’s efdoralprin alfa for alpha-1 antitrypsin deficiency related emphysema: Paris Thursday, December 18, 2025, 13:00 Hrs [IST] Sanofi, an R& ...

This combined model achieved a high level of accuracy, suggesting that imaging data alongside basic clinical information could be effective for screening.

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

The UCR accepts referrals from GPs, Hampshire hospitals, ambulance services, families, and patients themselves. It helps ...